Showing results (171-180 of 288) with videos related to

Sort By:
Pageof 29
American Heart Journal|May 27, 2003
Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries: results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART)Laura Mauri, Mark Reisman, Maurice Buchbinder, et al.
American Heart Journal|September 16, 2018
Rationale and design of the EVOLVE Short DAPT Study to assess 3-month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary interventionLaura Mauri, Ajay J Kirtane, Stephan Windecker, et al.
The American Journal of Cardiology|May 29, 2004
Effects of stent length and lesion length on coronary restenosisLaura Mauri, A James O'Malley, Donald E Cutlip, et al.
Circulation. Cardiovascular Quality and Outcomes|September 1, 2017
Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non-ST-Segment-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United StatesEric A Secemsky, Ajay Kirtane, Sripal Bangalore, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 20, 2015
Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial ProgramMohamed Abdel-Wahab, Franz-Joseph Neumann, Patrick Serruys, et al.
The American Journal of Cardiology|October 27, 2019
Interruption of Dual Antiplatelet Therapy Within Six Months After Coronary Stents (from the Dual Antiplatelet Therapy Study)Ada C Stefanescu Schmidt, Philippe Gabriel Steg, Robert W Yeh, et al.
JACC. Cardiovascular Interventions|November 14, 2016
Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United StatesEric A Secemsky, Ajay Kirtane, Sripal Bangalore, et al.
Circulation. Cardiovascular Quality and Outcomes|August 20, 2015
Enhancing the Prediction of 30-Day Readmission After Percutaneous Coronary Intervention Using Data Extracted by Querying of the Electronic Health RecordJason H Wasfy, Gaurav Singal, Cashel O'Brien, et al.
Circulation. Cardiovascular Interventions|April 10, 2016
Effectiveness of Arterial Closure Devices for Preventing Complications With Percutaneous Coronary Intervention: An Instrumental Variable AnalysisNeil J Wimmer, Eric A Secemsky, Laura Mauri, et al.
The American Journal of Cardiology|May 10, 2005
Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stentsLaura Mauri, A James O'Malley, Jeffrey J Popma, et al.
Pageof 29